宁波华翔：华翔启源与大寰机器人签订战略合作协议在灵巧手的研发等领域加强合作 宁波华翔公告，2025年12月22日，宁波华翔电子股份有限公司子公司宁波华翔启源科技有限公司与深圳 市大寰机器人科技有限公司共同签订了《战略合作协议》，为加快建设通用机器人产业，推动通用机器 人供应链示范和产品创新双驱动，本着依法合规、优势互补、友好协商、互利共赢的原则，双方拟在通 用人形机器人灵巧手的研发、制造和销售等领域加强合作。本协议无需提交公司董事会或者股东大会审 议，公司将根据后续合作业务的进展情况依法依规及时履行相应的决策程序及信息披露义务。 登录新浪财经APP 搜索【信披】查看更多考评等级 12月22日，旭升集团实际控制人变更为广州市人民政府；凌云光拟不超过500万美元认购智谱香港 IPO；华翔启源与大寰机器人签订战略合作协议，在灵巧手的研发等领域加强合作…… 以下是盘后公告精选： 旭升集团：实际控制人变更为广州市人民政府股票复牌 旭升集团公告，公司控股股东、实际控制人徐旭东及其一致行动人正在筹划涉及所持有公司股份转让事 宜，该事项可能导致公司控制权变更。2025年12月22日，徐旭东、陈兴方、旭晟控股、旭日实业与广州 ...

Core Viewpoint - Ningbo Huaxiang announced a strategic cooperation agreement with Shenzhen Dahuan Robot Technology to enhance collaboration in the research, manufacturing, and sales of general humanoid robot dexterous hands [1] Group 1 - Ningbo Huaxiang's subsidiary, Ningbo Huaxiang Qiyuan Technology Co., Ltd., is involved in the partnership [1] - The collaboration focuses on the development of humanoid robot technology, which is a growing sector in the robotics industry [1]

Group 1 - Tongyu Communication's subsidiary Zhonghong Tongyu plans to introduce Wuhan Wuchuang Institute as an investor through a capital increase of 10 million yuan, raising its registered capital from 200 million yuan to 210 million yuan, and reducing Tongyu's shareholding from 90% to 85.7143% [1] - Sanli Pharmaceutical signed a technology transfer contract with Hainan University to acquire the patent rights for the HXW2324 compound, aimed at developing new Alzheimer's disease treatments, for a total price of 200 million yuan [2] - Ningbo Huaxiang's subsidiary signed a strategic cooperation agreement with Shenzhen Dahuang Robot Technology to enhance collaboration in the development and manufacturing of general humanoid robot dexterous hands [3] Group 2 - Dook Culture announced a potential change in control, leading to a temporary suspension of its stock trading starting December 22, 2025, to ensure fair information disclosure [4] - Nanya New Materials plans to raise no more than 900 million yuan through a private placement to fund AI-based high-frequency copper-clad laminate projects and supplement working capital [5] - Hexing Packaging's major shareholder reduced their stake by 700,000 shares during a period of stock price volatility, consistent with previously disclosed plans [6] Group 3 - Yongding Co. plans to increase capital and introduce external investors, including Cambridge Technology, with a total cash increase of 55 million yuan, resulting in a decrease in its shareholding in Dingxin Optoelectronics [7] - ChaoSheng Electronics intends to invest 1 billion yuan in a high-performance HDI printed circuit board expansion and upgrade project, expecting to add an annual production capacity of 240,000 square meters [8] - Lingyi ZhiZao signed an agreement to acquire 35% of the shares of Limin Da for 875 million yuan, gaining control over 52.78% of the voting rights in the company [10] Group 4 - Sanhua Intelligent Control forecasts a net profit of 3.874 billion to 4.649 billion yuan for 2025, representing a year-on-year growth of 25% to 50% [11] - Aolian Electronics announced a potential change in control due to the planned transfer of shares by its major shareholder, leading to a temporary stock suspension starting December 22, 2025 [12]

Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]

Core Viewpoint - Ningbo Huaxiang's subsidiary, Huaxiang Qiyuan, has signed a strategic cooperation agreement with Shenzhen Dahuan Robot Technology to enhance the development and manufacturing of general-purpose humanoid robot dexterous hands, aiming to drive innovation in the robot supply chain and product development [1][2]. Group 1: Strategic Cooperation - The cooperation focuses on the development and mass production of a specific six-degree-of-freedom dexterous hand product, with Dahuan Robot responsible for product design and development verification, while Huaxiang Qiyuan handles solution confirmation, mass assembly, and sales to clients [1]. - This agreement is seen as a strategic extension of Huaxiang Qiyuan's main business, which will not alter the company's core operations or independence [2]. Group 2: Company Background and Future Outlook - Ningbo Huaxiang primarily engages in the design, development, production, and sales of automotive parts, serving major automotive manufacturers such as Volkswagen, Mercedes-Benz, BMW, and various domestic electric vehicle makers [2]. - The strategic partnership is expected to deepen the construction of the robot industry chain and accelerate the realization of Huaxiang Qiyuan's vision to become a "hardware manufacturing solution service provider" [2]. - The company plans to leverage its advanced manufacturing experience in the automotive parts sector to participate in the embodied intelligent robot industry chain, which may enhance operational efficiency and optimize cost structures in the long term [3].

Core Viewpoint - Ningbo Huaxiang (002048.SZ) has signed a strategic cooperation agreement with Shenzhen Dahuang Robot Technology Co., Ltd. to accelerate the development of the general robotics industry and enhance product innovation and supply chain demonstration in the field of general humanoid robot dexterous hands [1] Group 1: Strategic Cooperation - The agreement aims to strengthen collaboration in the research, manufacturing, and sales of general humanoid robot dexterous hands [1] - Both parties will focus on the development and mass production of a specific six-degree-of-freedom dexterous hand product based on the needs of Party A and its clients [1] Group 2: Responsibilities - Party B (Dahuang Robot) is responsible for product design and development validation, as well as the servo cylinder module [1] - Party A (Huaxiang) will handle the confirmation of the dexterous hand solution, mass assembly, and sales to Party A's clients [1]

【宁波华翔：子公司与大寰机器人签订战略合作协议 拟就特定六自由度灵巧手产品开展开发合作】智 通财经12月22日电，宁波华翔(002048.SZ)公告称，公司子公司宁波华翔启源科技有限公司与深圳市大 寰机器人科技有限公司签订《战略合作协议》，双方拟在通用人形机器人灵巧手的研发、制造和销售等 领域加强合作。双方就华翔启源及华翔启源客户机器人产品需求的特定六自由度灵巧手产品开展相关的 开发和量产方面的合作，其中大寰机器人负责产品设计及开发验证，伺服电缸模组，华翔启源负责灵巧 手方案确认、量产组装及华翔启源客户销售。 转自：智通财经 ...

Core Viewpoint - Ningbo Huaxiang announced a strategic cooperation agreement with Shenzhen Dahuan Robot Technology to enhance the development and innovation of general robotics, particularly in humanoid robot dexterous hands [1] Group 1: Strategic Cooperation - The agreement aims to accelerate the construction of the general robotics industry and promote a dual-driven approach for supply chain demonstration and product innovation [1] - Both parties will strengthen collaboration in the research, manufacturing, and sales of humanoid robot dexterous hands [1] Group 2: Compliance and Governance - The agreement does not require approval from the company's board of directors or shareholders [1] - The company will fulfill its decision-making procedures and information disclosure obligations in accordance with legal regulations based on the progress of subsequent cooperative business [1]

智通财经APP讯，宁波华翔(002048.SZ)发布公告，2025年12月22日，公司子公司宁波华翔启源科技有限 公司(以下简称"华翔启源")与深圳市大寰机器人科技有限公司(简称"大寰机器人")共同签订了《战略合 作协议》，为加快建设通用机器人产业，推动通用机器人供应链示范和产品创新双驱动，本着依法合 规、优势互补、友好协商、互利共赢的原则，双方拟在通用人形机器人灵巧手的研发、制造和销售等领 域加强合作。 华翔启源以"推动智能机器人普惠千行百业"为使命，自其成立以来专注于智能机器人的制造，通过本次 战略合作，华翔启源将进一步深化机器人产业链建设，加快实现"硬件制造解决方案服务商"的愿景目 标。 ...

Core Viewpoint - Ningbo Huaxiang (002048.SZ) has signed a strategic cooperation agreement with Shenzhen Dahuang Robot Technology Co., Ltd. to enhance collaboration in the development, manufacturing, and sales of general humanoid robot dexterous hands, aiming to accelerate the construction of the general robot industry and promote innovation in the supply chain and products [1] Group 1 - The strategic cooperation agreement was signed on December 22, 2025, between Huaxiang Qiyuan Technology Co., Ltd. (a subsidiary of Ningbo Huaxiang) and Dahuang Robot [1] - The collaboration focuses on the research and development of general humanoid robots, emphasizing compliance with laws, complementary advantages, friendly consultation, and mutual benefits [1] - Huaxiang Qiyuan aims to deepen the construction of the robot industry chain and accelerate its vision of becoming a "hardware manufacturing solution service provider" through this strategic partnership [1]